Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post
Binding Commitments Received for A$1.0 Million under Convertible Note Placement
next post
RHI: Acqn of royalty over Sandstone Gold Project tenements

Related Posts

6 Mining and Energy Stocks Make Top 10...

February 22, 2025

Silver47 Announces $14 Million Brokered LIFE Financing

August 26, 2025

FinEx Metals

June 24, 2025

Helium Stocks: 5 Biggest Canadian Companies in 2025

August 8, 2025

Sranan Gold Samples Additional High-Grade Gold Mineralization at...

August 1, 2025

Trump’s Sweeping Tariffs Ignite Global Trade War, Drawing...

April 4, 2025

Heaven’s Earthly Treasures: Behind the Metallurgy of the...

May 13, 2025

Silver Price Update: Q1 2025 in Review

April 10, 2025

Stallion Uranium Announces Update to Previously Announced Technology...

August 1, 2025

Top 5 Canadian Mining Stocks This Week: MAX...

November 1, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 2

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 6

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 7

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • Terms and conditions
    • Privacy Policy

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 daytradingreports.com | All Rights Reserved